Colorectal cancer and cardiovascular disease: double the burden when it comes to your health-related quality of life?

Abstract Background The prevalence of comorbid cardiovascular disease (CVD) among patients with colorectal cancer (CRC) has increased in the last decades. Previous studies have focused on the impact of comorbid CVD on clinical outcomes in CRC, while its impact on patients’ health-related quality of life (HRQoL) is understudied. This study, therefore, relates (new-onset) CVD to HRQoL (i.e., physical, role, cognitive, emotional, and social functioning, and two CVD-related symptom scales fatigue and dyspnea) in a two-year follow-up study among CRC patients. Materials and methods Newly diagnosed CRC patients from four Dutch hospitals were eligible for participation. Patients (N = 327) completed questions on HRQoL (EORTC QLQ-C30) and the presence and timing of CVDs before initial treatment (baseline) and one and two years after diagnosis. Results CRC patients with comorbid CVD at cancer diagnosis (n = 72, 22%) reported significantly worse physical functioning at 2-year follow-up compared with patients who never had comorbid CVD (p < .05). CRC patients with new-onset CVD (n = 36, 11%) reported worse global QoL, worse role functioning, and more fatigue at 1 and 2-year follow-up compared with patients who never had comorbid CVD. In addition, they reported more dyspnea at baseline and worse physical functioning at 2-year follow-up (p < .05). Finally, patients with new-onset CVD reported worse global quality of life at 1-year follow-up and worse role functioning and more fatigue at 2-year follow-up, compared with patients with comorbid CVD at cancer diagnosis (p < .05). All significant differences between the three groups were of clinical relevance. Conclusions CRC patients with CVD, specifically those with new-onset CVD, reported a significantly and clinically relevant worse HRQoL compared with those who never had comorbid CVD. These findings seem to indicate, although the number is small, that CRC patients might have cardiovascular needs that need to be addressed and that multidisciplinary care is recommended. Larger studies are needed to confirm this.

[1]  G. Nefs,et al.  Association between peripheral neuropathy and sleep quality among colorectal cancer patients from diagnosis until 2-year follow-up: results from the PROFILES registry , 2021, Journal of Cancer Survivorship.

[2]  F. Mols,et al.  Having co-morbid cardiovascular disease at time of cancer diagnosis: already one step behind when it comes to HRQoL? , 2019, Acta oncologica.

[3]  R. D. de Boer,et al.  Cancer and heart disease: associations and relations , 2019, European journal of heart failure.

[4]  B. Hemmelgarn,et al.  The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study , 2018, Journal of Cancer Survivorship.

[5]  L. V. van de Poll-Franse,et al.  Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based PROFILES registry , 2018, Quality of Life Research.

[6]  J. Richman,et al.  New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Ronald C. Chen,et al.  Comparison of Patient Report and Medical Records of Comorbidities: Results From a Population-Based Cohort of Patients With Prostate Cancer , 2017, JAMA oncology.

[8]  J. Denollet,et al.  Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors , 2017, Breast Cancer Research and Treatment.

[9]  C. Punt,et al.  Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group. , 2017, European journal of cancer.

[10]  N. Rottmann,et al.  Cardiovascular co-morbidity in cancer patients: the role of psychological distress , 2016, Cardio-Oncology.

[11]  Jin-ming Yu,et al.  The association between comorbidities and the quality of life among colorectal cancer survivors in the People’s Republic of China , 2016, Patient preference and adherence.

[12]  Tran Quoc Bao,et al.  Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants , 2016, The Lancet.

[13]  L. Køber,et al.  Incidence of cancer in patients with chronic heart failure: a long‐term follow‐up study , 2016, European journal of heart failure.

[14]  P. Elliott,et al.  Contributions of risk factors and medical care to cardiovascular mortality trends , 2015, Nature Reviews Cardiology.

[15]  Michael J. Solomon MBBCh MSc Fracs Frcsi,et al.  Which information source is best? Concordance between patient report, clinician report and medical records of patient co-morbidity and adjuvant therapy health information , 2015 .

[16]  M. Kohli,et al.  Evaluation and management of patients with heart disease and cancer: cardio-oncology. , 2014, Mayo Clinic proceedings.

[17]  Kirsten Vistisen,et al.  Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. , 2013, Cancer treatment reviews.

[18]  J. Coebergh,et al.  Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995–2010 , 2013, International journal of cancer.

[19]  G. Keel,et al.  Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? , 2013, Journal of Cancer Survivorship.

[20]  T. Djärv,et al.  Number and burden of cardiovascular diseases in relation to health-related quality of life in a cross-sectional population-based cohort study , 2012, BMJ Open.

[21]  J. Coebergh,et al.  The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. , 2011, European journal of cancer.

[22]  J. Coebergh,et al.  Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. , 2010, Critical reviews in oncology/hematology.

[23]  T. Blakely,et al.  The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study , 2009, BMC Cancer.

[24]  M. Tinetti,et al.  The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer , 2007, Cancer.

[25]  Graham A Colditz,et al.  Physical activity and survival after colorectal cancer diagnosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  K. Hoang-Xuan,et al.  The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. , 2005, European journal of cancer.

[27]  M. Liang,et al.  The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. , 2003, Arthritis and rheumatism.

[28]  Jun Ren,et al.  A retrospective cohort study , 2021 .

[29]  P. Fayers,et al.  Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  J. Aitken,et al.  Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. , 2011, European journal of cancer.

[31]  J. Coebergh,et al.  Comorbidity and colorectal cancer according to subsite and stage: a population-based study. , 2000, European journal of cancer.

[32]  C. Friedenreich,et al.  Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. , 1997, Journal of alternative and complementary medicine.

[33]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .